Compass Therapeutics CMPX
NASDAQ CMPX
$0.98 +0.08 (+8.65%)
As of: Oct 2, 2026 · 10:13 AM EDT

Compass Therapeutics (CMPX) Return on Sales [ROS] (2024 - 2025)

Updated

Compass Therapeutics' Return on Sales [ROS] came in at -7981.76% for Q2 2025, down 6211.76 percentage points from -1770.00% a year earlier.

Analysis

Compass Therapeutics (CMPX) Return on Sales [ROS] (2024 - 2025) Analysis & Trends

For FY2024, Compass Therapeutics' Return on Sales [ROS] was -6661.76%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.21%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 37.86%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -3.52%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 32.97%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 20.57%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.95%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -133.21%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 37.40%
10 Compass Therapeutics 187.29 Mn 187.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -7,981.76%
Dec 31, 2024 -6,662.12%
Sep 30, 2024 -6,523.18%
Jun 30, 2024 -1,770.00%
API Access

Compass Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CMPX&period=max&api_key=YOUR_API_KEY